Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Rexlemestrocel-L by Mesoblast for Hypoplastic Left Heart Syndrome: Likelihood of Approval
Rexlemestrocel-L is under clinical development by Mesoblast and currently in Phase II for Hypoplastic Left Heart Syndrome. According to GlobalData,...
Remestemcel-L by Mesoblast for Crohn's Disease (Regional Enteritis): Likelihood of Approval
Remestemcel-L is under clinical development by Mesoblast and currently in Phase III for Crohn's Disease (Regional Enteritis). According to GlobalData,...
Remestemcel-L by Mesoblast for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome: Likelihood of Approval
Remestemcel-L is under clinical development by Mesoblast and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory...
Remestemcel-L by Mesoblast for Graft Versus Host Disease (GVHD): Likelihood of Approval
Remestemcel-L is under clinical development by Mesoblast and currently in Pre-Registration for Graft Versus Host Disease (GVHD). According to GlobalData,...